secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-123466
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences enters ATM equity offering agreement with Jefferies LLC
----------------------------------------------------------------------------

- At-the-market facility permits sale of common stock from time to time; Jefferies acts as agent.
- Jefferies earns up to 3.0% commission on gross proceeds of shares sold under the agreement.
- Sales may occur on Nasdaq, in block trades, or privately; no minimum number of shares required.
- Either party may terminate the Sale Agreement at any time upon written notice.
- Shares to be issued under existing effective shelf registration statement (333-270760).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024123466/0000950170-24-123466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024123466/asmb-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer